NCT06626919 2026-02-25A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related DiseasesArcellx, Inc.Phase 1 Recruiting30 enrolled
NCT06193889 2026-01-30KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia GravisKyverna TherapeuticsPhase 2/3 Recruiting66 enrolled